Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT04504942 · COMPLETED
Trial details
- NCT number
- NCT04504942
- Sponsor
- CytoDyn, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2021-11-07
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.